Efficacy Trial of Gemcitabine Containing Regimens As Preoperative Chemotherapy in Non Small Cell Lung Cancer

• Status: Completed
• Trial end date: 2006-07-01
• Target enrollment: 0
• Participant gender: All

Summary

To evaluate the rate of complete pathological response after 3 cycles of gemcitabine containing chemotherapy.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Eli Lilly and Company
• Treatments: Albumin-Bound Paclitaxel; Carboplatin; Gemcitabine; Paclitaxel

Criteria

Inclusion Criteria:

• Histologically or cytologically confirmed non small cell lung cancer

• No prior chemotherapy or radiation for non small cell lung cancer

• No prior malignancy

Exclusion Criteria:

• Pregnancy or breastfeeding

• Serious concomitant disorders